153 related articles for article (PubMed ID: 17570705)
1. Bone mineral density deficits in pediatric patients treated for sarcoma.
Kaste SC; Ahn H; Liu T; Liu W; Krasin MJ; Hudson MM; Spunt SL
Pediatr Blood Cancer; 2008 May; 50(5):1032-8. PubMed ID: 17570705
[TBL] [Abstract][Full Text] [Related]
2. Late effects of chemotherapy and radiotherapy in osteosarcoma and Ewing sarcoma patients: the Italian Sarcoma Group Experience (1983-2006).
Longhi A; Ferrari S; Tamburini A; Luksch R; Fagioli F; Bacci G; Ferrari C
Cancer; 2012 Oct; 118(20):5050-9. PubMed ID: 22415578
[TBL] [Abstract][Full Text] [Related]
3. Comparison of mandibular cortical thickness and QCT-derived bone mineral density (BMD) in survivors of childhood acute lymphoblastic leukemia: a retrospective study.
Allen B; Migliorati C; Rowland C; An Q; Shintaku W; Donaldson M; Wells M; Kaste S
Int J Paediatr Dent; 2016 Sep; 26(5):330-5. PubMed ID: 26370921
[TBL] [Abstract][Full Text] [Related]
4. Osteoporosis in children and young adults: a late effect after chemotherapy for bone sarcoma.
Pirker-Frühauf UM; Friesenbichler J; Urban EC; Obermayer-Pietsch B; Leithner A
Clin Orthop Relat Res; 2012 Oct; 470(10):2874-85. PubMed ID: 22806259
[TBL] [Abstract][Full Text] [Related]
5. Early decrements in bone density after completion of neoadjuvant chemotherapy in pediatric bone sarcoma patients.
Müller C; Winter CC; Rosenbaum D; Boos J; Gosheger G; Hardes J; Vieth V
BMC Musculoskelet Disord; 2010 Dec; 11():287. PubMed ID: 21190557
[TBL] [Abstract][Full Text] [Related]
6. Pediatric Hodgkin lymphoma survivors at negligible risk for significant bone mineral density deficits.
Kaste SC; Metzger ML; Minhas A; Xiong Z; Rai SN; Ness KK; Hudson MM
Pediatr Blood Cancer; 2009 Apr; 52(4):516-21. PubMed ID: 19090552
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density in long-term survivors of highly malignant osteosarcoma.
Holzer G; Krepler P; Koschat MA; Grampp S; Dominkus M; Kotz R
J Bone Joint Surg Br; 2003 Mar; 85(2):231-7. PubMed ID: 12678358
[TBL] [Abstract][Full Text] [Related]
8. Retrospective Analysis of Outcomes of Patients with Relapsed, Refractory and Metastatic Sarcomas who have received Metronomic Chemotherapy.
Devadas SK; Banavali S
Gulf J Oncolog; 2019 May; 1(30):22-28. PubMed ID: 31242978
[TBL] [Abstract][Full Text] [Related]
9. The value of adjuvant chemotherapy in the management of sarcomas in children.
Donaldson SS
Cancer; 1985 May; 55(9 Suppl):2184-97. PubMed ID: 3884137
[TBL] [Abstract][Full Text] [Related]
10. Changes in bone mineral density in survivors of childhood acute lymphoblastic leukemia.
Kaste SC; Rai SN; Fleming K; McCammon EA; Tylavsky FA; Danish RK; Rose SR; Sitter CD; Pui CH; Hudson MM
Pediatr Blood Cancer; 2006 Jan; 46(1):77-87. PubMed ID: 16106430
[TBL] [Abstract][Full Text] [Related]
11. Late complications of therapy in 213 children with localized, nonorbital soft-tissue sarcoma of the head and neck: A descriptive report from the Intergroup Rhabdomyosarcoma Studies (IRS)-II and - III. IRS Group of the Children's Cancer Group and the Pediatric Oncology Group.
Raney RB; Asmar L; Vassilopoulou-Sellin R; Klein MJ; Donaldson SS; Green J; Heyn R; Wharam M; Glicksman AS; Gehan EA; Anderson J; Maurer HM
Med Pediatr Oncol; 1999 Oct; 33(4):362-71. PubMed ID: 10491544
[TBL] [Abstract][Full Text] [Related]
12. Bone mineral density in children with acute lymphoblastic leukemia.
Inaba H; Cao X; Han AQ; Panetta JC; Ness KK; Metzger ML; Rubnitz JE; Ribeiro RC; Sandlund JT; Jeha S; Cheng C; Pui CH; Relling MV; Kaste SC
Cancer; 2018 Mar; 124(5):1025-1035. PubMed ID: 29266176
[TBL] [Abstract][Full Text] [Related]
13. Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience.
Navid F; Santana VM; Billups CA; Merchant TE; Furman WL; Spunt SL; Cain AM; Rao BN; Hale GA; Pappo AS
Cancer; 2006 Apr; 106(8):1846-56. PubMed ID: 16541446
[TBL] [Abstract][Full Text] [Related]
14. Comparative renal tubular toxicity of chemotherapy regimens including ifosfamide in patients with newly diagnosed sarcomas.
Marina NM; Poquette CA; Cain AM; Jones D; Pratt CB; Meyer WH
J Pediatr Hematol Oncol; 2000; 22(2):112-8. PubMed ID: 10779023
[TBL] [Abstract][Full Text] [Related]
15. Sarcomas of the hand and foot: analysis of local control and functional result with combined modality therapy in extremity preservation.
Johnstone PA; Wexler LH; Venzon DJ; Jacobson J; Yang JC; Horowitz ME; DeLaney TF
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):735-45. PubMed ID: 8040019
[TBL] [Abstract][Full Text] [Related]
16. Paley's multiplier method does not accurately predict adult height in children with bone sarcoma.
Gilg MM; Wibmer C; Andreou D; Avian A; Sovinz P; Maurer-Ertl W; Tunn PU; Leithner A
Clin Orthop Relat Res; 2014 Aug; 472(8):2506-13. PubMed ID: 24777720
[TBL] [Abstract][Full Text] [Related]
17. Cyclophosphamide plus topotecan in children with recurrent or refractory solid tumors: a Pediatric Oncology Group phase II study.
Saylors RL; Stine KC; Sullivan J; Kepner JL; Wall DA; Bernstein ML; Harris MB; Hayashi R; Vietti TJ;
J Clin Oncol; 2001 Aug; 19(15):3463-9. PubMed ID: 11481351
[TBL] [Abstract][Full Text] [Related]
18. No impact of disease and its treatment on bone mineral density in survivors of childhood acute lymphoblastic leukemia.
Jain S; Jain S; Kapoor G; Virmani A; Bajpai R
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27671543
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte colony stimulating factor permits dose intensification by interval compression in the treatment of Ewing's sarcomas and soft tissue sarcomas in children.
Womer RB; Daller RT; Fenton JG; Miser JS
Eur J Cancer; 2000 Jan; 36(1):87-94. PubMed ID: 10741300
[TBL] [Abstract][Full Text] [Related]
20. Differential diagnosis of metastases in bone scans: chemotherapy induced bone necrosis.
Reuland P; Kaiserling E; Klingebiel T; Feine U; Niethammer D
Nuklearmedizin; 1999; 38(2):38-42. PubMed ID: 10100229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
